Phase II Evaluation of Liposomal Doxorubicin with Docetaxel in Patients with Metastatic Breast Cancer. (Record no. 21804012)

MARC details
000 -LEADER
fixed length control field 00867 a2200241 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516093255.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field ####s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1661-3791
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1159/000272119
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Fasano, Julie
245 00 - TITLE STATEMENT
Title Phase II Evaluation of Liposomal Doxorubicin with Docetaxel in Patients with Metastatic Breast Cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Breast care (Basel, Switzerland)
Date of publication, distribution, etc. Mar 2010
300 ## - PHYSICAL DESCRIPTION
Extent 17-21 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hershman, Dawn
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Novik, Yelena
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Levinson, Benjamin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Blozie, Kim
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tiersten, Amy D
773 0# - HOST ITEM ENTRY
Title Breast care (Basel, Switzerland)
Related parts vol. 5
-- no. 1
-- p. 17-21
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1159/000272119">https://doi.org/10.1159/000272119</a>
Public note Available from publisher's website

No items available.